Yukiya Yamamoto

Summary

Affiliation: Fujita Health University
Country: Japan

Publications

  1. doi request reprint Isolation of human mAbs that directly modulate FMS-related tyrosine kinase 3 signaling
    Yukiya Yamamoto
    Department of Hematology, School of Medicine, Fujita Health University, Aichi, Japan
    Cancer Sci 103:350-9. 2012
  2. doi request reprint BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia
    Yukiya Yamamoto
    Department of Hematology, School of Medicine, Fujita Health University, Toyoake, Aichi, Japan
    Blood 116:4274-83. 2010
  3. ncbi request reprint Chronic myeloid leukemia following chemotherapy with 5'-deoxy-5-fluorouridine for gastric cancer
    Motohiro Tsuzuki
    Department of Medicine, Fujita Health University, School of Medicine, Toyoake
    Intern Med 47:1739-41. 2008
  4. doi request reprint Differences in outcome for consecutive patients with diffuse large B-cell lymphoma before and after the advent of rituximab: a single-center experience
    Akinao Okamoto
    Fujita Health University School of Medicine, Toyoake, Japan
    Hematology 18:74-80. 2013
  5. doi request reprint A novel RUNX1-C11orf41 fusion gene in a case of acute myeloid leukemia with a t(11;21)(p14;q22)
    Akihiro Abe
    Department of Hematology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
    Cancer Genet 205:608-11. 2012
  6. doi request reprint Severe hepatitis associated with varicella zoster virus infection in a patient with diffuse large B cell lymphoma treated with rituximab-CHOP chemotherapy
    Akinao Okamoto
    Department of Hematology and Medical Oncology, Fujita Health University School of Medicine, 1 98 Dengakugakubo, Kutsukake cho, Toyoake 470 1192, Japan
    Int J Hematol 96:516-20. 2012
  7. ncbi request reprint Successful pregnancy in a patient with chronic myeloid leukemia under treatment with imatinib
    Motohiro Tsuzuki
    Department of Internal Medicine, Fujita Health University, School of Medicine, Toyoake
    Intern Med 48:1433-5. 2009

Collaborators

  • Akihiro Abe
  • Motohiro Tsuzuki
  • Masamitsu Yanada
  • Akinao Okamoto
  • Nobuhiko Emi
  • Masataka Okamoto
  • Shuichi Mizuta
  • Satoko Morishima
  • Masutaka Tokuda
  • Tadaharu Kanie
  • Yoshiki Akatsuka
  • Yoko Inaguma
  • Tomohiko Terazawa
  • Tetsushi Yoshikawa
  • Tsukane Kobayashi

Detail Information

Publications7

  1. doi request reprint Isolation of human mAbs that directly modulate FMS-related tyrosine kinase 3 signaling
    Yukiya Yamamoto
    Department of Hematology, School of Medicine, Fujita Health University, Aichi, Japan
    Cancer Sci 103:350-9. 2012
    ..In addition, 3E6 might be a potential scaffold for novel dendritic cell-based immunotherapies...
  2. doi request reprint BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia
    Yukiya Yamamoto
    Department of Hematology, School of Medicine, Fujita Health University, Toyoake, Aichi, Japan
    Blood 116:4274-83. 2010
    ..These results highlight essential features of pathogenesis in APL in more detail. BCOR appears to be involved not only in human congenital diseases, but also in a human cancer...
  3. ncbi request reprint Chronic myeloid leukemia following chemotherapy with 5'-deoxy-5-fluorouridine for gastric cancer
    Motohiro Tsuzuki
    Department of Medicine, Fujita Health University, School of Medicine, Toyoake
    Intern Med 47:1739-41. 2008
    ..He was placed on imatinib therapy, and achieved a major molecular response 10 months after the initiation of therapy. This is the first reported case of therapy-related CML following 5'-DFUR treatment...
  4. doi request reprint Differences in outcome for consecutive patients with diffuse large B-cell lymphoma before and after the advent of rituximab: a single-center experience
    Akinao Okamoto
    Fujita Health University School of Medicine, Toyoake, Japan
    Hematology 18:74-80. 2013
    ..Further investigations are warranted in the hope of improving outcomes for younger patients with DLBCL...
  5. doi request reprint A novel RUNX1-C11orf41 fusion gene in a case of acute myeloid leukemia with a t(11;21)(p14;q22)
    Akihiro Abe
    Department of Hematology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
    Cancer Genet 205:608-11. 2012
    ..This suggested that the RUNX1 breakpoint was in intron 6 and had generated alternative fusion splice variants. A reciprocal C11orf41-RUNX1 fusion was not detected. Thus, we identified C11orf41 as a novel fusion partner of RUNX1 in AML...
  6. doi request reprint Severe hepatitis associated with varicella zoster virus infection in a patient with diffuse large B cell lymphoma treated with rituximab-CHOP chemotherapy
    Akinao Okamoto
    Department of Hematology and Medical Oncology, Fujita Health University School of Medicine, 1 98 Dengakugakubo, Kutsukake cho, Toyoake 470 1192, Japan
    Int J Hematol 96:516-20. 2012
    ..We suggest that the use of chemotherapy for immune-suppressed elderly lymphoma patients may involve the risk of severe VZV infection...
  7. ncbi request reprint Successful pregnancy in a patient with chronic myeloid leukemia under treatment with imatinib
    Motohiro Tsuzuki
    Department of Internal Medicine, Fujita Health University, School of Medicine, Toyoake
    Intern Med 48:1433-5. 2009
    ..CML was in MMR at discovery of pregnancy and the fetus had been exposed to imatinib for 5 weeks. Treatment was discontinued, but MMR persisted during gestation...